Literature DB >> 22761410

Limitations of postmarketing surveillance in the analysis of risk of pregnancy loss associated with maternal mefloquine exposure.

Remington Lee Nevin.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 22761410     DOI: 10.1093/cid/cis601

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  2 in total

Review 1.  Mefloquine safety and tolerability in pregnancy: a systematic literature review.

Authors:  Raquel González; Urban Hellgren; Brian Greenwood; Clara Menéndez
Journal:  Malar J       Date:  2014-02-28       Impact factor: 2.979

2.  Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trial.

Authors:  Raquel González; Ghyslain Mombo-Ngoma; Smaïla Ouédraogo; Mwaka A Kakolwa; Salim Abdulla; Manfred Accrombessi; John J Aponte; Daisy Akerey-Diop; Arti Basra; Valérie Briand; Meskure Capan; Michel Cot; Abdunoor M Kabanywanyi; Christian Kleine; Peter G Kremsner; Eusebio Macete; Jean-Rodolphe Mackanga; Achille Massougbodgi; Alfredo Mayor; Arsenio Nhacolo; Golbahar Pahlavan; Michael Ramharter; María Rupérez; Esperança Sevene; Anifa Vala; Rella Zoleko-Manego; Clara Menéndez
Journal:  PLoS Med       Date:  2014-09-23       Impact factor: 11.069

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.